GMEDGLOBUS MEDICAL INC

NYSE globusmedical.com


$ 67.11 $ -0.42 (-0.61 %)    

Wednesday, 14-Aug-2024 12:24:42 EDT
QQQ $ 461.88 $ -1.71 (-0.37 %)
DIA $ 399.54 $ 1.81 (0.46 %)
SPY $ 542.65 $ -0.23 (-0.04 %)
TLT $ 97.94 $ 0.53 (0.54 %)
GLD $ 225.51 $ -2.50 (-1.1 %)
$ 67.32
$ 67.53
$ 66.50 x 100
$ 67.32 x 100
$ 66.73 - $ 67.56
$ 43.39 - $ 74.21
4,808,853
na
9.22B
$ 1.03
$ 226.71
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 02-21-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-21-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 02-17-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-04-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 02-17-2021 12-31-2020 10-K
16 10-28-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-20-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 02-21-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-02-2018 06-30-2018 10-Q
26 05-03-2018 03-31-2018 10-Q
27 02-22-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-04-2017 03-31-2017 10-Q
31 03-16-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 07-27-2016 06-30-2016 10-Q
34 05-04-2016 03-31-2016 10-Q
35 02-29-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 07-31-2015 06-30-2015 10-Q
38 05-05-2015 03-31-2015 10-Q
39 02-26-2015 12-31-2014 10-K
40 10-31-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-overweight-on-globus-medical-raises-price-target-to-93

Barclays analyst Matt Miksic maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $85 to ...

 rbc-capital-maintains-outperform-on-globus-medical-raises-price-target-to-78

RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and raises the price target from $76...

 truist-securities-maintains-hold-on-globus-medical-raises-price-target-to-79

Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Hold and raises the price target from...

 wells-fargo-upgrades-globus-medical-to-overweight-raises-price-target-to-78

Wells Fargo analyst Vik Chopra upgrades Globus Medical (NYSE:GMED) from Equal-Weight to Overweight and raises the price targ...

 needham-reiterates-hold-on-globus-medical

Needham analyst David Saxon reiterates Globus Medical (NYSE:GMED) with a Hold.

 globus-medical-q2-2024-adj-eps-075-beats-068-estimate-sales-629700m-beat-615345m-estimate

Globus Medical (NYSE:GMED) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.68 by...

 globus-medical-receives-fda-510k-clearance-for-excelsiusflex-and-actify-3d-total-knee-system

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it recently received 510(k) clea...

 truist-securities-maintains-hold-on-globus-medical-raises-price-target-to-78

Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Hold and raises the price target from...

 btig-maintains-buy-on-globus-medical-raises-price-target-to-75

BTIG analyst Ryan Zimmerman maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $72 to $75.

 morgan-stanley-maintains-equal-weight-on-globus-medical-raises-price-target-to-71

Morgan Stanley analyst Drew Ranieri maintains Globus Medical (NYSE:GMED) with a Equal-Weight and raises the price target fro...

 soft-inflation-data-boosts-small-caps-real-estate-regional-banks-traders-anticipate-fed-rate-cuts-as-stocks-react

U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cu...

 btig-maintains-buy-on-globus-medical-raises-price-target-to-72

BTIG analyst Ryan Zimmerman maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $63 to $72.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION